PRESS RELEASE published on 04/14/2023 at 17:06, 2 years 7 months ago NORNICKEL DISCONTINUES DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
PRESS RELEASE published on 04/06/2023 at 17:00, 2 years 7 months ago MMC Norilsk Nickel: NINE INDEPENDENT CANDIDATES ARE NOMINATED TO NORNICKEL’S BOARD OF DIRECTORS
PRESS RELEASE published on 03/17/2023 at 09:00, 2 years 8 months ago NORNICKEL COMPLETED SELF-ASSESSMENT FOR IRMA CERTIFICATION
PRESS RELEASE published on 02/22/2023 at 17:45, 2 years 9 months ago MMC Norilsk Nickel: THE BANK OF NEW YORK MELLON NOTIFIED OF THE TERMINATION OF THE DEPOSIT AGREEMENT FOR NORNICKEL’S ADR PROGRAM
PRESS RELEASE published on 02/10/2023 at 14:30, 2 years 9 months ago NORNICKEL REPORTS FULL YEAR 2022 AUDITED CONSOLIDATED IFRS FINANCIAL RESULTS
PRESS RELEASE published on 02/08/2023 at 15:00, 2 years 9 months ago POLAR LITHIUM, A JOINT VENTURE OF NORNICKEL AND ROSATOM, RECEIVES LICENSE TO DEVELOP KOLMOZERSKOYE PROJECT
PRESS RELEASE published on 01/24/2023 at 12:31, 2 years 10 months ago NORNICKEL ANNOUNCES CONSOLIDATED PRODUCTION RESULTS FOR 2022
Published on 12/05/2025 at 02:35, 4 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 12 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 51 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 17 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 27 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 32 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 27 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
